Announce Date | 06/03/2025 |
EPS Normalized Actual | $0.31 (Miss by $-0.0333) |
EPS GAAP Actual | $0.31 (Miss by $-0.0333) |
Revenue Actual | $0.894B |
Revenue Surprise | Beat by $894M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Apr 2030 | 1.91839 | 14.64 | 1.83366 | 2.1592 | 1 |
Apr 2029 | 0 | INF | 0 | 0 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Apr 2025) | 0.3089 | 0.3089 | 0.894B | -7.83% | 894M |
FQ1 2025 (Jan 2025) | 0.57 | 0.57 | 1.035B | -3.29% | 1035M |
FQ4 2024 (Oct 2024) | 0.55 | 0.55 | 1.095B | -1.1% | 1095M |
FQ3 2024 (Jul 2024) | 0.41 | 0.41 | 0.951B | -9.15% | 951M |
FQ2 2024 (Apr 2024) | 0 | 0 | 0.964B | -8.51% | 964M |
FQ1 2024 (Jan 2024) | 0.6 | 0.6 | 1.069B | -31.52% | 1069M |
FQ4 2023 (Oct 2023) | 0.5 | 0.5 | 1.107B | 100% | 1107M |
FQ3 2023 (Jul 2023) | 0.48 | 0.48 | 1.038B | 100% | 1038M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Jan 2028) | 0.50058 | -- | 0.48224 | 0.52087 | 1 |
FQ4 2027 (Oct 2027) | 0.52336 | -- | 0.50418 | 0.54457 | 1 |
FQ3 2027 (Jul 2027) | 0.37897 | -- | 0.36508 | 0.39433 | 1 |
FQ2 2027 (Apr 2027) | 0.48103 | -- | 0.48103 | 0.48103 | 0 |
FQ1 2027 (Jan 2027) | 0.53886 | -- | 0.53886 | 0.53886 | 0 |
FQ4 2026 (Oct 2026) | 0.60715 | -- | 0.60715 | 0.60715 | 0 |
FQ3 2026 (Jul 2026) | 0.53299 | -- | 0.53299 | 0.53299 | 0 |
FQ2 2026 (Apr 2026) | 0.40298 | 23.35 | 0.40298 | 0.40298 | 0 |
FQ1 2026 (Jan 2026) | 0.49319 | -15.57 | 0.49319 | 0.49319 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Jan 2028) | 1.05B | -- | 1.02B | 1.09B | 9 |
FQ4 2027 (Oct 2027) | 1.05B | -- | 1.02B | 1.08B | 6 |
FQ3 2027 (Jul 2027) | 0.95B | -- | 0.92B | 0.98B | 6 |
FQ2 2027 (Apr 2027) | 1.07B | -- | 1.07B | 1.07B | 0 |
FQ1 2027 (Jan 2027) | 1.22B | -- | 1.22B | 1.22B | 0 |
FQ4 2026 (Oct 2026) | 1.22B | -- | 1.22B | 1.22B | 0 |
FQ3 2026 (Jul 2026) | 1.1B | -- | 1.1B | 1.1B | 0 |
FQ2 2026 (Apr 2026) | 1.05B | 14.49 | 1.05B | 1.05B | 0 |
FQ1 2026 (Jan 2026) | 1.13B | 8.75 | 1.13B | 1.13B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | 0.3089 | 0.3089 | 100% | |
FQ1 2025 (Jan 2025) | 0.57 | 0.57 | 100% | |
FQ4 2024 (Oct 2024) | 0.55 | 0.55 | 100% | |
FQ3 2024 (Jul 2024) | 0.41 | 0.41 | 100% | |
FQ2 2024 (Apr 2024) | 0 | 0 | NAN% | |
FQ1 2024 (Jan 2024) | 0.6 | 0.6 | 100% | |
FQ4 2023 (Oct 2023) | 0.5 | 0.5 | 100% | |
FQ3 2023 (Jul 2023) | 0.48 | 0.48 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | $0B | $0.89B | $894M | 100% |
FQ1 2025 (Jan 2025) | $0B | $1.04B | $1035M | 100% |
FQ4 2024 (Oct 2024) | $0B | $1.1B | $1095M | 100% |
FQ3 2024 (Jul 2024) | $0B | $0.95B | $951M | 100% |
FQ2 2024 (Apr 2024) | $0B | $0.96B | $964M | 100% |
FQ1 2024 (Jan 2024) | $0B | $1.07B | $1069M | 100% |
FQ4 2023 (Oct 2023) | $0B | $1.11B | $1107M | 100% |
FQ3 2023 (Jul 2023) | $0B | $1.04B | $1038M | 100% |